The first-quarter earnings season for the Medical sector will be in full swing this week as several drugmakers are slated to ...

Viatris VTRS, a global healthcare company, is scheduled to report first-quarter 2025 results on May 8, 2025. The Zacks ...

Amgen’s product sales are expected to have been driven by strong volume growth of products like Evenity, Repatha, Kyprolis ...

Investors in Denali Therapeutics Inc (Symbol: DNLI) saw new options begin trading this week, for the December 19th expiration. One of the key inputs that goes into the price an option buyer is ...

NASDAQ:DNLI opened at $12.74 on Friday. Denali Therapeutics has a twelve month low of $10.57 and a twelve month high of $33.33. The firm has a market capitalization of $1.85 billion, a price-to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Denali Therapeutics (NASDAQ:DNLI) Inc on Friday, setting a price... ByInvesting.com • Aug 07, 2020 Alzheimer's players in the green ...